The Food and Drug Administration has proposed a rule that would require notices for food substances claimed to be generally recognized as safe, commonly called GRAS. The proposal is not yet law. It is a formal rulemaking that is open for public comment through December 9, and any final rule could change after the agency reviews the record.
The proposal centers on a long-standing part of U.S. food law. Substances intentionally added to food are generally treated as food additives and are subject to premarket review unless an exception applies. One exception is when qualified experts generally recognize a substance as safe for its intended use. The FDA’s proposal would require submission of GRAS notices for human and animal food substances asserted to qualify under that exception.
What GRAS means today
GRAS is an acronym for “generally recognized as safe.” Under the existing framework, the FDA explains that recognition can be based on scientific procedures or, for certain uses of substances in food before 1958, on common use in food. Scientific recognition must be supported by the same quantity and quality of evidence required for a food-additive approval, according to the agency’s GRAS overview.
The current notification system has been voluntary. Companies may submit notices to FDA describing the basis for a GRAS conclusion, but the proposed rule addresses whether submission should instead be mandatory for uses covered by the proposal. The agency says the change is intended to enhance oversight and transparency.
What the proposal would do
The proposed rule published in the Federal Register says FDA would require submission of GRAS notices for the use of a human or animal food substance purported to be GRAS under the conditions of intended use. The rulemaking describes proposed changes to regulations covering definitions, eligibility, notice submission, electronic filing, English translations, public disclosure and related procedures.
That does not mean every ingredient on a supermarket shelf would immediately change, or that the FDA has declared existing GRAS uses unsafe. The proposal is about the notification pathway and the information FDA receives before uses are asserted as GRAS. Readers should be cautious about headlines that imply an immediate ban, universal recall or a final regulatory decision. None of those outcomes is established by the proposed rule itself.
Why the public-comment period matters
Federal rulemaking is a public process. FDA is seeking feedback on the proposal, and comments may be submitted under docket number FDA-2025-N-3262. The Federal Register notice lists December 9, 2026, as the deadline for electronic or written comments.
Public comments can address implementation questions, potential costs, scientific standards, exemptions, timing and the clarity of the proposed text. Stakeholders may include food manufacturers, ingredient suppliers, consumer advocates, scientific organizations, veterinarians and members of the public. The agency will evaluate the comments before deciding whether to issue a final rule and what that final rule should say.
What consumers should know now
For consumers, the immediate change is informational rather than a new instruction about what to buy or avoid. The rule is proposed, not final. The FDA continues to maintain resources about GRAS notices, food additives and ingredient oversight. People with food-allergy concerns or medical questions should continue to rely on product labels and guidance from qualified health professionals rather than assuming that a regulatory proposal changes the safety status of a particular product.
The proposal may still matter over time because the amount and visibility of information available to FDA can affect how ingredient uses are reviewed. The agency says it is seeking a final approach that protects consumers and improves transparency. Whether the final regulation achieves that aim will depend on the rule’s eventual language, implementation schedule and the evidence in the public record.
How to follow the process
Readers can review the FDA’s GRAS overview and the Federal Register proposed rule. NY Breaking News will distinguish proposal-stage actions from final rules in its Health coverage.
Sources: U.S. Food and Drug Administration, Generally Recognized as Safe; Federal Register, Substances Generally Recognized as Safe proposed rule.
